Montespace-L Tablet is a combination medication containing levocetirizine 5mg and montelukast 10mg, indicated for the relief of symptoms associated with allergic rhinitis, asthma, and chronic idiopathic urticaria. The product acts synergistically to provide effective treatment of these conditions. Levocetirizine, an H1 receptor antagonist, helps to alleviate symptoms such as sneezing, runny nose, and itchy eyes, while montelukast, a leukotriene receptor antagonist, inhibits the synthesis of bronchospasm-inducing leukotrienes, thereby reducing bronchospasm and improving lung function. The combination therapy provides a broader range of therapeutic benefits, including improved nasal congestion, sinus pressure, and itching, as well as reduced airway constriction. Montespace-L Tablet is suitable for patients with chronic or intermittent allergic rhinitis, exercise-induced bronchospasm, or mild to moderate asthma. The product is available in a standardized tablet form, ensuring consistent dosing and patient compliance. It is contraindicated in patients with hypersensitivity to either levocetirizine or montelukast, and caution is advised in patients with a history of cardiovascular disease, renal impairment, or liver disease.